Bariatric Surgery Devices – Medical Devices Pipeline Assessment, 2019

Bariatric Surgery Devices are used to perform bariatric surgery are referred to as bariatric surgery devices. GlobalData's Medical Devices sector report, “Bariatric Surgery Devices – Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Bariatric Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Bariatric Surgery Devices Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Bariatric Surgery Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Bariatric Surgery Devices pipeline products.

Review of Recent Developments in the segment / industry

The Bariatric Surgery Devices Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Bariatric Surgery Devices under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023

• 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape

• 56,000+ medical equipment company profiles

• 4,300+ company profiles of medical equipment manufacturers in China and India

• 2,000+ company profiles of medical equipment manufacturers in Japan

• 825+ companies’ revenue splits and market shares

• 1,900+ quarterly and annual medical equipment company financials

• 940+ medical equipment company SWOTs

• 21,500+ pipeline product profiles

• 34,500+ marketed product profiles

• 36,000+ clinical trials

• 36,500+ trial investigators

• 5,400+ reports on companies with products in development

• 33,000+ deals in the medical equipment industry

• 1,300+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Bariatric Surgery Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Bariatric Surgery Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Bariatric Surgery Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

3DT Holdings LLC

Allurion Technologies, Inc.

Applied Medical Resources Corporation

BAROnova Inc

BFKW, LLC

Boston Scientific Corp

C. R. Bard Inc

Columbia University

EndoRetics Inc.

EndoVx Inc

Gelesis Inc

GI Dynamics Inc

Hebrew University of Jerusalem

Innovia LLC

Johns Hopkins University

Medi-Globe GmbH

MetaModix, Inc

Mmtc, Inc.

Nanyang Technological University

Obalon Therapeutics Inc

Precision Medical Devices Inc

ReShape Lifesciences Inc

Satiety Inc (Inactive)

Sensate LLC

Silhouette Medical, Inc.

SLIMEDICS LTD

Spatz FGIA, Inc

The Sheikh Zayed Institute for Pediatric Surgical Innovation

TransEnterix Inc

Tulip Medical Ltd.

UAS LifeSciences LLC

University of Florida

University of Miami

ValenTx Inc

Vibrynt, Inc. (Inactive)

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Bariatric Surgery Devices Overview 8

3 Products under Development 9

3.1 Bariatric Surgery Devices – Pipeline Products by Stage of Development 9

3.2 Bariatric Surgery Devices – Pipeline Products by Segment 10

3.3 Bariatric Surgery Devices – Pipeline Products by Territory 11

3.4 Bariatric Surgery Devices – Pipeline Products by Regulatory Path 12

3.5 Bariatric Surgery Devices – Pipeline Products by Estimated Approval Date 13

3.6 Bariatric Surgery Devices – Ongoing Clinical Trials 14

4 Bariatric Surgery Devices – Pipeline Products under Development by Companies 15

4.1 Bariatric Surgery Devices Companies – Pipeline Products by Stage of Development 15

4.2 Bariatric Surgery Devices – Pipeline Products by Stage of Development 17

5 Bariatric Surgery Devices Companies and Product Overview 18

5.1 3DT Holdings LLC Company Overview 18

5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Allurion Technologies, Inc. Company Overview 19

5.2.1 Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Applied Medical Resources Corporation Company Overview 22

5.3.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 22

5.4 BAROnova Inc Company Overview 23

5.4.1 BAROnova Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 BFKW, LLC Company Overview 24

5.5.1 BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 Boston Scientific Corp Company Overview 25

5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 C. R. Bard Inc Company Overview 26

5.7.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.8 Columbia University Company Overview 27

5.8.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 27

5.9 EndoRetics Inc. Company Overview 28

5.9.1 EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

5.10 EndoVx Inc Company Overview 29

5.10.1 EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 Gelesis Inc Company Overview 30

5.11.1 Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 GI Dynamics Inc Company Overview 32

5.12.1 GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 Hebrew University of Jerusalem Company Overview 36

5.13.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 Innovia LLC Company Overview 37

5.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.15 Johns Hopkins University Company Overview 39

5.15.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 Medi-Globe GmbH Company Overview 40

5.16.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 MetaModix, Inc Company Overview 41

5.17.1 MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.18 Mmtc, Inc. Company Overview 43

5.18.1 Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

5.19 Nanyang Technological University Company Overview 44

5.19.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 44

5.20 Obalon Therapeutics Inc Company Overview 45

5.20.1 Obalon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 Precision Medical Devices Inc Company Overview 46

5.21.1 Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.22 ReShape Lifesciences Inc Company Overview 47

5.22.1 ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.23 Satiety Inc (Inactive) Company Overview 50

5.23.1 Satiety Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 50

5.24 Sensate LLC Company Overview 51

5.24.1 Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.25 Silhouette Medical, Inc. Company Overview 52

5.25.1 Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

5.26 SLIMEDICS LTD Company Overview 53

5.26.1 SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview 53

5.27 Spatz FGIA, Inc Company Overview 54

5.27.1 Spatz FGIA, Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.28 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 55

5.28.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview 55

5.29 TransEnterix Inc Company Overview 56

5.29.1 TransEnterix Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.30 Tulip Medical Ltd. Company Overview 57

5.30.1 Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57

5.31 UAS LifeSciences LLC Company Overview 58

5.31.1 UAS LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview 58

5.32 University of Florida Company Overview 59

5.32.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 59

5.33 University of Miami Company Overview 60

5.33.1 University of Miami Pipeline Products & Ongoing Clinical Trials Overview 60

5.34 ValenTx Inc Company Overview 61

5.34.1 ValenTx Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.35 Vibrynt, Inc. (Inactive) Company Overview 64

5.35.1 Vibrynt, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 64

6 Bariatric Surgery Devices- Recent Developments 65

6.1 Jul 17, 2018: BAROnova Announces Submission of Premarket Approval Application to the U.S. FDA for the TransPyloric Shuttle Device Intended for the Treatment of Obesity 65

6.2 Jul 16, 2018: Surefire Medical Names Anil Singhal As Board Director 65

6.3 Jul 04, 2018: NHS EndoBarrier Service Shows Patients Maintain Treatment Effect Six Months Post Explant 66

6.4 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 67

6.5 Jun 27, 2018: ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference 68

6.6 Jun 19, 2018: ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest 68

6.7 Jun 06, 2018: FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon 68

6.8 Jun 05, 2018: Harry Leider, Former Chief Medical Officer of Walgreens, Joins Gelesis as Chief Medical Officer, and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, Joins the Gelesis Board of Directors 69

6.9 Jun 05, 2018: Apollo Endosurgery Announces Presentation of Mayo Clinic’s Clinical Study of ORBERA Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis at Digestive Disease Week 2018 70

6.10 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 72

6.11 Jun 04, 2018: Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA Intragastric Balloon System 73

6.12 Jun 04, 2018: Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week 2018 titled: “Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon” 74

6.13 Jun 04, 2018: FDA Alerts Health Care Providers about 5 Additional Deaths Associated with the use of Liquid-filled Intragastric Balloon Devices for Obesity Treatment 75

6.14 May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors 76

6.15 May 24, 2018: Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week 2018 Conference 76

6.16 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 77

6.17 May 22, 2018: BMI of Texas Patient Loses 210 Pounds after Sleeve Gastrectomy & Receives American Heart Association Lifestyle Change Award 79

6.18 May 14, 2018: ReShape Lifesciences Announces Record Revenue for First Quarter 2018 80

6.19 May 14, 2018: BTL AT 79TH CMEF 2018 81

6.20 May 10, 2018: Obalon Announces First Quarter 2018 Financial Results 81

6.21 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 82

6.22 May 07, 2018: Todd Wood joins Obalon Therapeutics as Vice President Global Sales 82

6.23 May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results 83

6.24 Apr 26, 2018: Vizient Names David F. Ertel as New Chief Financial Officer 84

6.25 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 84

6.26 Apr 24, 2018: ReShape Lifesciences Continues to Grow Presence in Middle East with Distribution in Bahrain 86

6.27 Apr 23, 2018: Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon – ORBERA365 – in the Kingdom of Saudi Arabia 86

6.28 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang 87

6.29 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 88

6.30 Apr 03, 2018: BTL to Unveil Groundbreaking Research and Latest Innovation at the American Society for Laser Medicine & Surgery's Annual Conference 89

6.31 Apr 02, 2018: ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results 91

6.32 Mar 12, 2018: Apollo Endosurgery Announces Conclusion of LAP-BAND Low BMI Post-Approval Study 92

6.33 Mar 05, 2018: Obalon Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results 93

6.34 Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results 94

6.35 Feb 26, 2018: Nine More Healthcare Systems Will Provide 3D Mammography Imaging With Installation Of Fujifilm's ASPIRE Cristalle 96

6.36 Feb 26, 2018: Apollo Endosurgery Announces First ORBERA U.S. Post-Approval Publication 97

6.37 Feb 22, 2018: Apollo Endosurgery Announces MFDS Approval for the ORBERA Intragastric Balloon System in South Korea, a Non-Surgical Solution to Assist Patients with Weight Loss 98

6.38 Feb 22, 2018: Next Step Bionics & Prosthetics Fits LUKE Arm to Do More for More People 99

6.39 Feb 22, 2018: ReShape Lifesciences Technologies to be Featured at Minimally Invasive Surgery Symposium 100

7 Appendix 101

7.1 Methodology 101

7.2 About GlobalData 104

7.3 Contact Us 104

7.4 Disclaimer 104

List of Tables

Table 1: Bariatric Surgery Devices – Pipeline Products by Stage of Development 9

Table 2: Bariatric Surgery Devices – Pipeline Products by Segment 10

Table 3: Bariatric Surgery Devices – Pipeline Products by Territory 11

Table 4: Bariatric Surgery Devices – Pipeline Products by Regulatory Path 12

Table 5: Bariatric Surgery Devices – Pipeline Products by Estimated Approval Date 13

Table 6: Bariatric Surgery Devices – Ongoing Clinical Trials 14

Table 7: Bariatric Surgery Devices Companies – Pipeline Products by Stage of Development 15

Table 8: Bariatric Surgery Devices – Pipeline Products by Stage of Development 17

Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 18

Table 12: Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 18: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 22

Table 21: BAROnova Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 24: BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Table 27: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25

Table 30: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 33: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 27

Table 36: EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 39: EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 42: Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 47: GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 55: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 36

Table 58: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Table 65: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 39

Table 68: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 40

Table 71: MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Table 76: Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

Table 79: Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 44

Table 82: Obalon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 85: Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 88: ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 93: Satiety Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 50

Table 96: Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview 51

Table 99: Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

Table 102: SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview 53

Table 105: Spatz FGIA, Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Table 108: The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview 55

Table 111: TransEnterix Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Table 114: Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57

Table 117: UAS LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview 58

Table 120: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 59

Table 123: University of Miami Pipeline Products & Ongoing Clinical Trials Overview 60

Table 126: ValenTx Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Table 132: Vibrynt, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 64

Table 135: Glossary 103

List of Figures

Figure 1: Bariatric Surgery Devices – Pipeline Products by Stage of Development 9

Figure 2: Bariatric Surgery Devices – Pipeline Products by Segment 10

Figure 3: Bariatric Surgery Devices – Pipeline Products by Territory 11

Figure 4: Bariatric Surgery Devices – Pipeline Products by Regulatory Path 12

Figure 5: Bariatric Surgery Devices – Pipeline Products by Estimated Approval Date 13

Figure 6: Bariatric Surgery Devices – Ongoing Clinical Trials 14

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports